ProShares UltraShort Profile

PR

Performance

0 / 100

Odds of Distress

74
Equity ratings for ProShares UltraShort Nasdaq Bio are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting October 26, 2019 and ending today January 24, 2020. Click here to learn more.

ProShares UltraShort Profile

The etf is currently experiencing active upward rally. The investment seeks daily investment results that correspond to two times the inverse of the daily performance of the Nasdaq Biotechnology Index. ProShares UltraShort is traded on BATS Exchange in USA. more on ProShares UltraShort
Legal NameProShares UltraShort Nasdaq Bio
CEOMukhtar KalyanView All
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
IssuerProShares
DescriptionProShares UltraShort Nasdaq Biotechnology
Inception Date2010-04-06
BenchmarkNasdaq Biotech Index
Entity TypeRegulated Investment Company
Asset Under Management21.26 Million
Average Trading Valume64,235.8
Asset TypeEquity
CategorySector
FocusHealth Care
Market ConcentrationDeveloped Markets
RegionNorth America
AdministratorJ.P. Morgan Investor Services Co.
AdvisorProShare Advisors LLC
CustodianJPMorgan Chase Bank, N.A.
DistributorSEI Investments Distribution Co.
Portfolio ManagerMichael Neches, Tarak Dave
Transfer AgentJPMorgan Chase Bank, N.A.
Fiscal Year End31-May
ExchangeNASDAQ
Number of Constituents51.0
Market MakerVirtu Financial
Total Expense1.11
Management Fee0.75
Nav Price13.02
Two Hundred Day Average16.92
Ytd-41.01%
Average Daily Volume In Three Month79.71k
Fifty Two Week Low12.77
As Of DateDecember 31, 2019
Average Daily Volume Last 10 Day76.03k
Fifty Two Week High21.45
One Month-1.95%
Fifty Day Average13.47
Three Month-32.85%
ProShares UltraShort Nasdaq Bio [BIS] is traded in USA and was established 2010-04-06. The fund is classified under Trading--Inverse Equity category within ProShares family. ProShares UltraShort currently have 21.25 M in assets under management (AUM). , while the total return for the last 3 years was -26.88%.
Check ProShares UltraShort Probability Of Bankruptcy

Sector Allocation (%)

ProShares UltraShort Target Price Odds Analysis

Odds Below 14.24HorizonTargetOdds Above 14.24
40.12%30 days 14.24 59.75%
Based on normal probability distribution, the odds of ProShares UltraShort to move above current price in 30 days from now is about 59.75 (This ProShares UltraShort Nasdaq Bio probability density function shows the probability of ProShares UltraShort Etf to fall within a particular range of prices over 30 days) .

ProShares UltraShort Risk Profiles

ProShares UltraShort Technical Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. ProShares UltraShort Tangent Of Price Series is a trigonometric price transformation method View also all equity analysis or get more info about tangent of price series math transform indicator.

ProShares UltraShort Against Markets

Did you try this?

Run Idea Analyzer Now

   

Idea Analyzer

Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
All  Next Launch Module
Continue to Trending Equities. Please also try Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Company logos by clearbit